TY - JOUR T1 - Genetic Variability, Haplotype Structures, and Ethnic Diversity of Hepatic Transporters MDR3 (<em>ABCB4</em>) and Bile Salt Export Pump (<em>ABCB11</em>) JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 1582 LP - 1599 DO - 10.1124/dmd.105.008854 VL - 34 IS - 9 AU - Thomas Lang AU - Michael Haberl AU - Diana Jung AU - Anja Drescher AU - Robert Schlagenhaufer AU - Andrea Keil AU - Esther Mornhinweg AU - Bruno Stieger AU - Gerd A. Kullak-Ublick AU - Reinhold Kerb Y1 - 2006/09/01 UR - http://dmd.aspetjournals.org/content/34/9/1582.abstract N2 - Biliary excretion of bile salts and other bile constituents from hepatocytes is mediated by the apical (canalicular) transporters P-glycoprotein 3 (MDR3, ABCB4) and the bile salt export pump (ABCB11). Mutations in ABCB4 and ABCB11 contribute to cholestatic diseases [e.g., progressive familial intrahepatic cholestasis 2 (PFIC2), PFIC3, and intrahepatic cholestasis of pregnancy], and our objective was to establish genetic variability and haplotype structures of ABCB4 and ABCB11 in healthy populations of different ethnic backgrounds. All coding exons, 5 of 6 noncoding exons, 50 to 300 base pairs of the flanking intronic regions, and 2.5 to 2.8 kilobase pairs of the promoter regions of ABCB4 and ABCB11 were sequenced in 159 and 196 DNA samples of Caucasian, African-American, Japanese, and Korean origin. In total, 76 and 86 polymorphisms were identified in ABCB4 and ABCB11, respectively; among them, 14 and 28 exonic polymorphisms, and 8 and 10 protein-altering variants, of which 4 were predicted to have functional consequences. Both genes showed substantial ethnic differences with respect to allele number, frequency of common and population-specific sites, and patterns of linkage disequilibrium. Population genetic analysis suggested some selective pressure against changes in the protein, supporting the important endogenous role of these transporters. Haplotype variability was greater in ABCB11 than in ABCB4. An ABCB11 promoter haplotype was associated with significant decrease of activity compared with wild type. Our results contribute to a better understanding of the molecular basis and of ethnic differences in drug response, and provide a valuable tool for future research on the heredity of cholestatic liver injury. The American Society for Pharmacology and Experimental Therapeutics ER -